Chronic infection by HBV is the leading cause of hepatocellular carcinoma in man. Several lines of evidence suggest that the viral transactivator HBx plays a critical role in the molecular pathogenesis of HBVrelated HCC. To study the actual impact of HBx and the mechanism of its action, we have recently cloned and characterized a set of X-sequences from HCC in patients with chronic infection by HBV. In the present study, we have compared the eects of HBx and its naturally arising mutants on cell growth and viability. We report that HBx inhibits clonal outgrowth of cells and induces apoptosis by a p53-independent pathway. Furthermore, HBx expression induced a late G1 cell cycle block prior to their counterselection by apoptosis. Importantly, mutations in the HBx-gene evolving in hepatocellular carcinoma abolished both HBx-induced growth arrest and apoptosis. Using a panel of engineered mutants we have mapped the growth suppressive eect of HBx to domains shown to be required for its transactivating function. Based on these results, we propose that abrogation of the anti-proliferative and apoptotic eects of HBx by naturally occurring mutations might render the hepatocytes susceptible to uncontrolled growth and contribute to multistep hepatocarcinogenesis associated with HBV-infection.
Introduction
Hepatitis B virus (HBV) belongs to the family hepadnaviridae which replicate their genome by reverse transcription and causes both acute and chronic infection of the liver. Based on epidemiological data, it is generally accepted that HBV plays a major causative role in the development of hepatocellular carcinoma (HCC) in man (for a review, see Hildt et al., 1996; Yen, 1996) . The question whether HBV is directly involved in the multistep hepatocarcinogenesis remains to be answered. No transforming viral oncogene has been identi®ed so far and several factors including persistent in¯ammation, insertional mutagenesis, and expression of certain viral gene products have been linked to development of HCC. The great majority of HCCs contain clonally integrated HBV-sequences, however, cis-activation/ inactivation of a cellular gene critical for cell growth has been only rarely reported thus far (for a review, see Hildt et al., 1996) . In most of the integrated subviral genomes the X-ORF is maintained and expressed Unsal et al., 1994) suggesting a selective growth advantage for cells containing this sequence. X-gene is highly conserved among all mammalian hepadnaviruses and encodes a small polypeptide, which is expressed at low level during natural course of HBV infection (for a review, see Yen, 1996) . The role of HBx in viral life cycle has not been clearly de®ned, although genetic studies in woodchucks indicate that functional HBx is required for infectivity of WHV (Chen et al., 1993; Zoulim et al., 1994) . The seminal observation that HBx transactivates several cellular genes regulating cell growth has suggested that HBx may induce uncontrolled cell proliferation (for a review, see Yen, 1996) . Consistent with this notion, it has been shown that HBx can induce cell proliferation in quiescent ®broblasts (Koike et al., 1994) , and deregulate cell cycle check points (Benn and Schneider, 1995) . Furthermore, HBx induces HCC in certain transgenic mice (Kim et al., 1991) . However, in a dierent genetic context, HBx transgenic mice show either no obvious pathology (Lee et al., 1990) , only increased susceptibility to chemical carcinogens (Slagle et al., 1996) , or acceleration of the development of c-mycinduced HCC (Terradillos et al., 1997) . Only a few studies have shown transformation of certain cell types by HBx in vitro (Hohne et al., 1990; Shirakata et al., 1989) . Thus, the actual impact of HBx in liver carcinogenesis and the mechanisms of its action remain largely obscure.
The relevance of the transactivation function of HBx in the viral life cycle and oncogenesis is unclear, however, it is generally believed that it is crucial. HBx has been shown to activate a wide variety of cellular and viral genes in trans including the HBV enhancers, the HIV long-terminal repeats, class II and III promoters, proto-oncogenes c-jun, c-fos and c-myc (Yen, 1996) . The fact that HBx by itself does not bind to dsDNA and that genes stimulated by HBx lack any obvious consensus sequences (Rossner, 1992) suggest that HBx stimulates transcription presumably by interacting with cellular proteins and/or components of signal transduction pathways. Indeed the transactivation function of HBx has been shown to involve both direct interaction with transcriptional factors such as RPB5 of RNA polymerases (Cheong et al., 1995) , TATA-binding protein (Quadri et al., 1995) or ATF/ CREB (Maguire et al., 1991; Williams and Andrisani, 1995) and activation of signal transduction pathways such as ras/raf/MAP-kinase (Benn and Schneider, 1994) , protein kinase C (PKC) (KekuleÂ et al., 1993) .
Although HBx seems to act in the nucleus to activate transcription, the great majority of HBx is cytosolic (Doria et al., 1995; Sirma et al., 1998) and this strongly suggests that it stimulates promoters bearing AP-1, or NF-kB sites in a compartment external of nucleus (Chirillo et al., 1996; Doria et al., 1995; Sirma et al., 1998) . Consistent with this notion, certain proteases and the proteasome (Fischer et al., 1995; Huang et al., 1996; Sirma et al., 1998) have been reported to be potential targets of HBx. Finally, previous studies point to a direct interaction of HBx with p53 (Feitelson et al., 1993; Truant et al., 1995; Wang et al., 1994) as well as DNA repair factor involved in nucleotide excision repair (Lee et al., 1995) , suggesting a direct link to cellular DNA repair, cell growth and apoptosis. In fact, several reports have provided evidence that HBx does modulate apoptosis (Chirillo et al., 1997; Kim et al., 1998; Oguey et al., 1996; Terradillos et al., 1998) although the ®nal outcome of the pleiotropic eects of HBx on cell cycle and viability is still highly debated. These diculties are thought to be largely due to its heterologous and ectopic expression in various cellular environments.
In the present study we comparatively analysed the biological activity HBx and its mutants isolated from hepatocellular carcinoma in vitro. We demonstrate that HBx inhibits the clonal outgrowth of cells by inducing a late G1 cell cycle arrest followed by their demise by apoptosis. Importantly, we describe the existence of natural mutants arising in HCC that have lost both growth suppressive and apoptotic activities. Furthermore, using arti®cial mutants the antiproliferative eects of HBx could be mapped to domains of HBx shown to be critical for its transcriptional activation property. We propose that abrogation of the anti-proliferative and apoptotic eects of HBx by naturally occurring mutations might render the hepatocytes susceptible to uncontrolled growth.
Results

HBx, but not its tumor-derived mutants, suppresses colony formation
Colony formation is a very sensitive measure to determine the global eects of gene of interest on cell growth. To study the eects of HBx on cell growth, we performed colony formation assay in both differentiated murine hepatocytes from mice transgenic for transforming growth factor a(a-ML) (Oguey et al., 1996) and undierentiated human Chang cells. Cells were transfected with HBx, p53 or empty parental vector (pcDNA3) carrying the neomycin gene. Cells were subcultured 36 h later into medium containing G418. Drug resistant colonies appeared 10 ± 14 days later, were ®xed and stained with GIEMSA and quanti®ed. As shown in Figure 1 , HBx, and not of the parental vector caused a substantial reduction in the number of colonies in both a-ML and Chang cells to an extent comparable to that of p53. To examine the contribution of p53 to HBx-induced suppression of colony formation, the eect of HBx expression on Saos-2 cells, in which the p53 gene is inactivated by deletion, was tested. A dramatic reduction in the number of colonies was also observed in these cells (Figure 1 ), indicating that p53 is not required for HBx induced growth suppression. From these experiments we conclude that HBx potently inhibited the clonal outgrowth of cells and that p53 is dispensable for its antiproliferative eects.
If the growth suppressive eect of HBx has in vivo relevance, one might expect release of such an inhibitory eect in clonally expanding tumor cells having retained the X-ORF. To address this point, we cloned and characterized the ORF encoding X in HCCs from patients with chronic infection by HBV. The amino acid sequences of X-ORFs derived from both tumoral (T) and non-tumoral (NT) tissues are comparatively shown in Figure 2 . As you can see the HBx encoding sequences from four analysed HCC (Patients C, M, F and G, referred to as: CT, MT, FT and GT) contained several point mutations distributed in dierent domains of HBx. In addition, a frame-shift in the X-ORF of patient F (FT) generated a new stop codon, resulting in the loss of the C-terminal 26 aa. A C-terminal truncation was also shown for patient G (GT), due to HBV DNA insertion in the cellular genome. In two of these cases (patients C and M) non-tumoral tissue was also available for analysis. In one of them (patient C), the HBx-sequence (referred to as: CNT) matched exactly with that of the reference sequence corresponding to the ayw-subtype.
To study and determine the colony forming eciencies of this set of natural HBx mutants, we have transfected Chang, a-ML and primary REF. The outcome of this experiment is shown in Figure 3 . In sharp contrast to wild type HBx, tumor-derived integrated mutants of HBx (CT, MT, and FT), failed to suppress colony formation in Chang, a-ML, REF ( From this experiment, we conclude that mutants of HBx arising in HCC have lost their growth suppressive property in contrast to HBx and CNT.
HBx, but not its tumor-derived mutants, induces apoptosis
Suppression of colony formation might be due to cell demise. To address this point, Chang cells were transfected with HBx, or the parental empty vector and the DNA-content was determined 48 h and 96 h later by FACS. Cells transfected with HBx, and not control cells, revealed a large population with sub-G1 DNA-content ( Figure 4a ). Bivariate FACS analysis showed that only HBx expressing cells (X+) exhibited hypoploid DNA-content (5G1) (Figure 4a , X versus vector). Cells expressing X-GFP, but not GFP, showed chromatin condensation and nuclear fragmentation (Figure 5a and b) , fenestration in the Lamin ring ( Figure 5c ) and DNA degradation as evidenced by TUNEL assay (Figure 5d ). In contrast with these results, none of the HBx mutants induced apoptosis (Figure 4b CT) . Collectively, these observations suggest that the abrogation of the growth suppressive eects of HBx by mutations could result from a loss-of-function of the HBx protein.
HBx causes cell cycle arrest at the G1/S transition
To characterize the early events preceding the apoptotic demise of cells 48 h and 72 h upon expression of HBx, we have determined their cell cycle status at 36 h after transfection. Asynchronous Chang cells were transfected with vectors encoding HBx-GFP and p53 ( Figure 6 ). The percentage of transfected cells ranged from 60 ± 70%, as estimated in parallel transfections using vectors encoding GFP, or LacZ genes. The analysis of the DNA-content of Chang cells 36 h after transfection revealed that, in contrast to control cells (G1: 42.4%; S: 26.4%; G2/ M: 31.2%), HBx-expressing cells accumulated in G1 (G1: 84.1%; S: 9.8%; G2/M: 6.1%), with a cell cycle pro®le comparable to that of p53-transfected control cells (Figure 6a ). In contrast with these results, none of the HBx mutants showed such G1 arrest (data not shown). To further demonstrate that HBx blocked cell cycle progression in G1, we measured BrdU incorporation. Consistent with the FACS data cells expressing HBx lacked any incorporated BrdU suggesting absence of DNA synthesis (Figure 6b lower panel) . We also determined the expression of certain cell cycle regulators. Asynchronous, untransfected, Chang cells (Figure 6c lane 1) showed a major hyper-phosphorylated Rb and an elevated cyclin A2-associated CDK2 activity, consistent with their uncontrolled cell proliferation. In contrast, cells transfected with the p53-expressing plasmid showed a mixing of hyper-and hypo-phosphorylated Rb, together with a decreased cyclin A2-associated CDK2 activity, consistent with the G1 block in p53-expressing cells (Ko and Prives, 1996) . Cells transfected with the HBx-expressing plasmid showed a majority hyperphosphorylated Rb, consistent with a late G1 arrest. In addition, the elevated cyclin A2-associated CDK2 activity observed in these cells further suggested a late G1 block, occurring at the G1/S transition ( Figure 6c ). Hyperphosphorylated Rb and elevated cyclin A2-associated CDK2 activity are indeed characteristic features of late G1 arrest and our results show that, in this cell type and with these levels of ectopic expression, HBx arrests the cells at the G1/S stage of the cell cycle progression.
In vitro expression, localization and transactivation capacity of HBx mutants
Mutations in the X-gene could have detrimental eects on protein stability and could potentially account for the dierent results in assays presented before. To address this issue we have performed immunoblot analysis in extracts of Chang cells transfected with vectors encoding HBx, or its natural mutants. CT, CNT, MT, MNT and GT were clearly detected by Western blot (representative cases are shown in Figure 7a ). In vitro translation of FT ( Figure 7b ) and immunoblot analysis of an arti®cial myc-tagged C-terminal deletion mutant, DX128, (Figure 7c) showed that the apparent absent, or diminished expression of FT, or MT and MNT, respectively, are due to mutational loss of epitopes in this domain of HBx (Figures 7a and 5) . Consistent with this idea, MT-GFP and MNT-GFP accumulated to the same levels as X-GFP, when revealed with GFP antiserum (Figure 7d) . Thus, these data demonstrates that the dierential behavior of HBxmutants in colony formation assays is not due to protein stability as compared to their wild type counterpart.
We next compared the intracellular distribution of HBx to that of its mutants. As previously reported, HBx accumulated as granula in the cytosol (Figure 7e) ; the distribution pattern of CT (Figure 7e) , MNT, MT and GT (data not shown) was comparable to that of HBx. In contrast, FT showed a nucleo-cytoplasmic distribution (Figure 7e) . A similar nucleocytoplasmic localization of the C-terminal deletion mutant of HBx, DX128-myc, (Figure 7f ) suggested that this moiety accounts at least in part for the cytosolic retention HBx.
The transcriptional activity of HBx appeared to be important for its pleiotropic cellular eects. We therefore analysed the transactivating capacity of HBx and its mutants (CT, MT, MNT, FT and GT) on NF-kB using gel shift and/or luciferase assays in Chang cells. As shown in Figure 7g (lanes 2 ± 4) wild type CNT, like TNFa and Tax, induced a p50/p65 containing complex, as recently reported (Chirillo et Sirma et al., 1998; Su and Schneider, 1997) . In contrast, this complex was absent in cells expressing the mutants (representative cases are shown in lanes 5 ± 8).
In summary, these results demonstrated that natural mutants of HBx having lost their antiproliferative eect are also defective in transactivation assays.
Transcriptional activity by HBx is essential for its growth suppressive eect
Since none of the natural mutants of HBx interfered with cell growth, and since they had lost their transactivation property, we wondered whether the antiproliferative eect of HBx was linked to its function as a transactivator. Therefore, we compared colony formation eciencies of a set of engineered HBx-mutants with well characterized transactivation properties (Runkel et al., 1993) . Mutants MX4 and MX9 could still activate AP-1 and NF-kB-dependent transcription, while MX6, MX13 (Runkel et al., 1993) and DX128 (data not shown) lacked these activities. As shown in Figure 8 , mutations of the transactivationrelevant domains of HBx abolished the ability of the mutant proteins to suppress the clonal outgrowth of Chang cells. Mutants conserving their transcriptional activity were found to be as ecient inhibitors of cell growth as HBx wt. Thus, the transactivation capacity of HBx is essential for its antiproliferative eects.
Discussion
To investigate the potential impact of HBx on liver carcinogenesis associated with chronic HBV-infection, we used a genetic approach and comparatively analysed the eects of HBx and its natural mutants selected in human HCC on cell growth and viability. We demonstrate that in vivo mutations of HBx could abolish its growth suppressive and apoptotic eects. This study therefore oers a ®rst evidence for the relevance of HBx mutations expressed in human HCC. Our investigation showed that a primary eect of overexpression of HBx is suppression of cell growth as evidenced by reduction in the number of colonies obtained. Furthermore, ongoing HBx overexpression led to chromatin condensation and fragmentation, disruption of the nuclear membrane, and the appearance of hypoploid cells, thus demonstrating that HBx can, at least under certain experimental conditions, induce apoptosis. Our results agree with recent reports on the reduction of cell colonies Oguey et al., 1996) , cell cycle arrest , inhibition of transformation as well as induction of (Chirillo et al., 1997; Kim et al., 1998; Terradillos et al., 1998) or sensitization (Su and Schneider, 1997) to apoptosis by HBx. On the other hand, they dier from those which showed cell cycle progression upon HBx expression (Benn and Schneider, 1995; Koike et al., 1994) , inhibition of p53-dependent apoptosis (Elmore et al., 1997) . HBx regulates multiple transduction pathways, and it is plausible that these discrepancies are due to the signal cascades activated in dierent cell types, combined with the expression system and level achieved. Several lines of evidence indeed suggest that the intracellular concentration of HBx might be a critical determinant of the ®nal phenotypic eect of HBx expression. In particular, recent in vivo studies in HBx-expressing transgenic mice have shown that a high level of HBx expression, detectable in the early post-natal period by Western blot analysis of whole liver extracts and by immunohistochemistry in most hepatocytes, is associated to an increased liver cells apoptosis (Terradillos et al., 1998) . In contrast, this eect was not anymore observed at latter stages, when HBx expression was markedly decreased to barely detectable level.
Thus, it is plausible that during early stages of HBV infection, HBx expression might be sucient to induce or sensitize to apoptosis in infected hepatocytes. Induction of apoptosis might favor propagation of the viral particles, a mechanism already proposed for (Desaintes et al., 1997; Westendorp et al., 1995; Yamada et al., 1994) . Decreased HBx expression, as observed during the progressive diminution of HBV multiplication, would abolish this eect and, instead, allow stimulation of cell proliferation. Consistent with this view is the low expression of HBx in tumor cells (Su et al., 1998) . Our results oer a complementary hypothesis to explain the clonal expansion of liver cells expressing HBx. Given the diculties in interpretating data obtained from ectopic expression of HBx, we indeed reasoned that, if the growth suppressive eect of HBx has in vivo relevance, one might expect release of such an inhibitory eect in clonally expanding tumor cells having retained a mutated X-ORF. Our results demonstrate that the properties of all in vivo integrated tumor mutants analysed were indeed in sharp contrast with those of wild type HBx. In fact, inhibition of colony formation and apoptosis were abrogated in all mutated sequences. We therefore hypothesize that liver cells containing loss of function mutations in the X-ORF would be selected and clonally expanded during the multistep hepatocarcinogenesis. In line with these hypotheses, it is interesting to note that one of the mutants (MNT) isolated from non-tumoral tissues showed several point mutations and abolition of growth suppression. These data are consistent with HBx mutations impacting on early steps of liver carcinogenesis, an issue which will now be testable in chronically infected subjects without HCC. We have previously shown that HCC tissue cells continue to transcribe and express HBx RNA and protein, respectively, despite extinction of HBV envelope and capsid proteins expression (Poussin et al., 1999; Paterlini et al., 1995) . Our present data lead to hypothesize that, at least in some HCC tissues, this protein may be functionally inactivated by mutations and/or deletions. Clearly, this does not exclude that in other HCC tissues integrated HBx may retain transactivation properties (Wollersheim et al., 1988) .
The concept that a putative oncogene can modulate both the cell cycle and apoptosis has now been well established for several viral proteins, such as the E1A protein of adenovirus 5 (for a review, see Mymryk, 1996) , E2 protein of papillomaviruses (Desaintes et al., 1997; Goodwin et al., 1998) , and the Tax protein of HTLV-1 (Chlichia et al., 1995) . It can be interpreted as further evidence for the common pathways used by viruses to subvert cell cycle and cell death regulation. Our cell cycle data indeed suggest that an early eect of HBx expression, during infection by a non-lytic virus such as HBV, is to`activate' quiescent hepatocytes and maintain them in this state in G1 of the cell cycle as reported for the Tax protein of HTLV-1 (Chlichia et al., 1995) . It has been shown that HBV replication depends on cell cycle and dierentiation status and is decreased in S phase (Ozer et al., 1996) . Thus, maintenance of activated cells in late G1 might favor further rounds of HBV-DNA replication by inducing expression of liver speci®c transcription and replication factors, as increasing the pool of free dNTPs (Goulaoui et al., 1994) . In this view, the late induction of apoptosis might re¯ect prolonged expression of HBx in cells blocked at G1/S phase. It will be important, however, to verify the impact of these ®ndings, obtained in undierentiated transformed cells, in dierentiated hepatocytes.
The mechanisms by which the wild type HBx acts to suppress the cell growth as well as the biological function of the mutants are not clear. However, we have shown that the natural mutants showed a strong reduction in their transactivating eect on NF-kB. In addition, using a panel of arti®cial mutants, we further Figure 8 Matural and arti®cial mutations rendering the HBx defective in transactivation abolish also its growth suppressive eects. Chang cells were transfected with indicated plasmids. Drug-resistant colonies were ®xed, stained with Giemsa and quanti®ed. Colony formation eciencies were calculated on the basis of parental vector alone (100%) correlated the transactivation capacity of HBx, whether due to point mutations and/or C-terminal deletions, with its growth inhibitory potency. Recent studies established cell type-speci®c, proapoptotic (Lin et al., 1998; Marianneau et al., 1997) , or antiapoptotic (Bellas et al., 1997; Van Antwerp et al., 1996) functions for the transcription factor NF-kB (Lipton, 1997) . Thus, NFkB activates multiple, often interrelated, signaling pathways leading to apoptosis, or survival. Our observation suggests, therefore, that the ®nal outcome of HBx expression on cell viability might depend on a balance between these pro-apoptotic and anti-apoptotic eects of NF-kB in a given cell type.
Comparison of the X-ORF did not reveal any speci®c domain of the HBx protein where the mutations would be clustered. One of these natural mutants (FT) was, however, particularly interesting. Both point mutations and a C-terminal truncation were indeed present. This mutant showed both abrogation of cell growth inhibition and transactivation, and nucleo-cytoplasmic localization. Since identical properties were shown for an arti®cial mutant lacking the same C-terminal amino acids, our data further support the in vivo role of this domain in transactivation and also growth suppressive eect of HBx. Altogether, these results therefore suggest that the transactivating eect of HBx is involved in cell growth inhibition and that mutants de®ning the domains involved provide dissecting tools for the study of the role of HBx in viral life cycle and hepatocarcinogenesis.
Materials and methods
Plasmids and HBx sequences
The construction of wild type HBx, HBx-GFP, HBx-Flag has been previously described (Sirma et al., 1998) . Isolation and characterization of X-ORFs from the tumoral and nontumoral tissues from patients with HCC has been reported in detail elsewhere (Poussin et al., 1999) Brie¯y, DNA was extracted from frozen tumoral tissues from four patients with HCC, one of these being HBsAg positive and three HBsAg negative, but HBV DNA positive in the liver samples. To distinguish between integrated HBV genomes from replicative viral genomes, with potentially very dierent biological eects, we combined two approaches: we studied HCCs in which the pregenomic HBV RNA was undetectable by RT ± PCR (for the HBsAg negative cases : patients C, M and F) and we used an Alu ± PCR based assay (for the HBsAg positive case referred as GT) (Minami et al., 1995) . The ampli®ed X sequences were subcloned into HindIII and SalI sites of the mammalian expression vector pcDNA3 (Invitrogen).
An engineered deletion mutant lacking the last 26 Cterminal amino acids, referred to as DX128, was generated by PCR and subcloned in pcDNA3. HBx-mutants containing two codon (AP) insertions (Runkel et al., 1993) were subcloned into a eukaryotic expression plasmid driven by the CMV promoter (kindly provided by H Will and S-F Chang, Hamburg).
Cells and transfections
a-ML (Oguey et al., 1996) , Saos-2, NIH3T3, primary REF (Bio-Whittaker Bioproducts) , and Chang cells were cultured in DMEM medium supplemented with 10% fetal bovine serum. Transfections were carried out using the calcium phosphate co-precipitation technique.
Colony formation assay
Cells were transfected with 10 mg cDNAs as indicated and subcultured (1 : 4) 36 h later in medium containing G418 (800 mg/ml). Drug-resistant colonies appearing 10 ± 14 days later were ®xed, stained with Giemsa and counted.
FACS analysis
Determination of DNA content by FACS has been described previously (Sirma et al., 1998) . Cell cycle distribution of cells expressing HBx, or p53 was analysed by selecting GFPpositive cells, or immunolabeled p53 with a¯uorescent intensity greater than the background level.
BrdU incorporation
Twenty-four hours after transfection with HBx plasmid, Chang cells were exposed to BrdU (3 mg/ml) for 12 h before being immunostained for HBx and BrdU, as described (Attardi et al., 1996) .
Evaluation of apoptosis
This was performed by combining, FACS, DNA staining with the DNA-dye 7-actinomycin D, qualitative analysis of DNA-fragmentation by low molecular weight DNA gel electrophoresis and TUNEL assay. Nuclear membrane disruption was visualized by immunostaining using an antiLamin antibody (Dr Courvalin, Paris, France).
Immunoblot analysis
Proteins from total cell extracts were fractionated on SDSpolyacrylamide gels, transferred onto Immobilon membranes (Millipore), and blots probed with indicated antisera were revealed with an enhanced chemiluminescence system according to the manufacturer's instructions (Pierce). HBx antiserum #70606 has been already described elsewhere (Urban et al., 1997; Su et al., 1998) .
In vitro translation assay
Translations were carried out using the TNT coupled reticulocyte system (Promega).
Kinase assay
Cell extracts (100 mg) were subjected to immunoprecipitation with an anti-cyclin A2-antibody and collected on protein ASepharose beads. H1-kinase reactions were performed for 30 min at 308C. The reaction products were fractionated on 12% SDS-polyacrylamide gel and visualized by autoradiography.
Electrophoretic mobility shift assay
Nuclear extracts were prepared and analysed according to protocols previously described (Sirma et al., 1998) . Nuclear extract (5 mg) was incubated with an end-labeled, partially double-stranded, NF-kB-speci®c oligonucleotide probe, KBF1.
Luciferase assay
Luciferase assays were performed as previously described (Sirma et al., 1998 
